Daxor Corporation (DXR) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $11.85
• Market Cap: $70.63M
• P/E Ratio: 75.75
• EPS: $0.16
• 52-Week High: $14.76
• 52-Week Low: $7.10

Market Sentiment

Daxor Corporation currently has a Bullish sentiment score of 0.33.

About Daxor Corporation

Daxor Corporation (DXR) is a pioneering medical device company headquartered in New York, dedicated to revolutionizing patient care through advanced blood volume monitoring technology. Specializing in cryobank and biotechnology services, Daxor's innovative solutions are designed to transform blood management practices within healthcare facilities across the United States. With a strong emphasis on improving health outcomes, Daxor leverages its proprietary technologies and cutting-edge researc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Daxor Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DXR pay dividends?

Daxor Corporation (DXR) does not currently pay a regular dividend.

What is DXR's P/E ratio?

Daxor Corporation has a price-to-earnings (P/E) ratio of 75.75.

What is DXR's market cap?

Daxor Corporation (DXR) has a market capitalization of $70.63M with a current stock price of $11.85.